Skip to content

TO COMPARE THE EFFECT OF HYPERBARIC LEVOBUPIVACAINE O.5% AND HYPERBARIC ROPIVACAINE 0.75 % IN SPINAL ANAESTHESIA IN PATIENTS UNDERGOING LOWER LIMB ORTHOPEDIC SURGERIES

COMPARATIVE STUDY OF HYPERBARIC LEVOBUPIVACAINE O.5% AND HYPERBARIC ROPIVACAINE 0.75 % IN SPINAL ANAESTHESIA IN PATIENTS UNDERGOING LOWER LIMB ORTHOPEDIC SURGERIES - Nil

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061783
Enrollment
100
Registered
2024-01-24
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M966- Fracture of bone following insertion of orthopedic implant, joint prosthesis, or bone plate

Interventions

Intervention1: Levobupivacaine (H) 0.5%: With due approval from institutional ethical committee, A 50 participants who will be undergoing various lower limb orthopaedic surgeries will be given inj.Lev

Sponsors

Jawaharlal Nehru Medical College and Hospitals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients posted for elective Lowerlimb orthopaedic surgery ASA status 1 and 2

Exclusion criteria

Exclusion criteria: Age less than 20 years and age above 60 years ASA status 3 and 4 Any known hypersensitivity or contra indication to bupivacaine or ropivacaine Patients with history of coagulopathy Patients with spine deformity Patients with local skin infection at site of injection Patients who had shivering even before administering spinal anaesthesia

Design outcomes

Primary

MeasureTime frame
Duration of AnalgesiaTimepoint: Perioperatively,at 5 min, at 10min

Secondary

MeasureTime frame
Onset & duration of sensory block Onset & duration of motor block Haemodynamic variabilityTimepoint: Perioperatively,at 5 min, at 10 min

Countries

India

Contacts

Public ContactDr Maina Singh

Jawaharlal Nehru Medical College and Hospitals , Ajmer , Rajasthan

mainasingh111@gmail.com9414097045

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026